This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Talcott JA, Finberg R, Mayer RJ, Goldman L (1988) The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 142: 2561–2568
Talcott JA, Siegel RD, Mayer RJ, Goldman L (1992) Risk assessment in cancer patients with fever and neutropenia; a prospective, two center validation of a prediction rule. J Clin Onc 10: 316–322
Lukas KG, Brown AE, Armstrong D, Chapman D, Heller G The identification of febrile, neutropenic children with neoplastic disease at lowrisk for bacteremia and complication for sepsis. Cancer 77: 791–798
Cometta A, Zinner S, de Bock R et al (1994) Piperacillin-tazobactam plus amikacin versus ceftazidime plus amkicacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 39: 1309–1313
Cometta A, Calandra T, Gaya H et al (1996) Monotherapy with Meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 40: 1108–1115
Preis S, Jürgens H, Freidland C, Oudekotte-David AA, Thomas L, Göbel U (1993) Ceftriaxone alone or in combination with teicoplanin in the mangagement of febrile episodes in neutropenic children and adolescents with cancer on an outpatient base. Klin Pädiatr 205: 295–299
Fauser AA, Lang E, Köchling G, Daschner, FD (1994) A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients. Infection 11: 271–275
Ter Braak, E, De Vries, PJ, Bouter, KP et al (1990) Once-daily dosing regimen for aminoglycoside plus ß-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. American Journal of Medicine 89: 58–66
EORTC (1993) Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The international antimicrobial therapy cooperative group of the EORTC. Ann Intern Med 119: 584–593
Malik LA, Khan WA, Aziz Z, Karim M (1994) Self-administered antibiotic therapy for chemotherapy induced, low-risk febrile neutropenia with non-hematologic neoplasms. Clin Infect Dis 19: 522–527
Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on validated prediction rule. JCO 12: 107–114
Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, Schmitt J, Adam D (1994) Empirische antimikrobielle Therapie bei neutropenischen Patienten. Med Klin 89: 114–123
Rolston KVI (1996) Outpatient management of fever in neutropenic patients. Current Opinion in Infectious Diseases 9: 407–410
Pizzo PA(1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323–1332
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Karthaus, M., Wolf, HH., Kämpfe, D., Ritter, J., Peters, G., Jürgens, H. (1998). Management of Febrile Neutropenia in 396 Episodes in Acute Leukemia Patients with Once-Daily Administration of Ceftriaxone. In: Hiddemann, W., et al. Acute Leukemias VII. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71960-8_149
Download citation
DOI: https://doi.org/10.1007/978-3-642-71960-8_149
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71962-2
Online ISBN: 978-3-642-71960-8
eBook Packages: Springer Book Archive